AI-quantified epicardial adipose tissue and prediction of future myocardial infarction in patients with cardiometabolic disease: a post-hoc analysis from the SCOT-HEART trial.

AI-quantified epicardial adipose tissue and prediction of future myocardial infarction in patients with cardiometabolic disease: a post-hoc analysis from the SCOT-HEART trial. Cardiovasc Diabetol. 2025 Oct 22; 24(1):403.

View in: PubMed

subject areas

Adipose Tissue
Adiposity
Aged
Computed Tomography Angiography
Coronary Angiography
Coronary Artery Disease
Female
Humans
Male
Metabolic Syndrome
Middle Aged
Myocardial Infarction
Pericardium
Plaque, Atherosclerotic
Predictive Value of Tests
Prognosis
Risk Assessment
Risk Factors

authors with profiles

Aryabod Razipour, MD